288 related articles for article (PubMed ID: 17264855)
1. Efficient whole-body transduction with trans-splicing adeno-associated viral vectors.
Ghosh A; Yue Y; Long C; Bostick B; Duan D
Mol Ther; 2007 Apr; 15(4):750-5. PubMed ID: 17264855
[TBL] [Abstract][Full Text] [Related]
2. Systemic Trans-splicing adeno-associated viral delivery efficiently transduces the heart of adult mdx mouse, a model for duchenne muscular dystrophy.
Ghosh A; Yue Y; Shin JH; Duan D
Hum Gene Ther; 2009 Nov; 20(11):1319-28. PubMed ID: 19627234
[TBL] [Abstract][Full Text] [Related]
3. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
Koo T; Popplewell L; Athanasopoulos T; Dickson G
Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
[TBL] [Abstract][Full Text] [Related]
4. Design of trans-splicing adeno-associated viral vectors for Duchenne muscular dystrophy gene therapy.
Lai Y; Li D; Yue Y; Duan D
Methods Mol Biol; 2008; 433():259-75. PubMed ID: 18679629
[TBL] [Abstract][Full Text] [Related]
5. Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency.
Xu Z; Yue Y; Lai Y; Ye C; Qiu J; Pintel DJ; Duan D
Hum Gene Ther; 2004 Sep; 15(9):896-905. PubMed ID: 15353044
[TBL] [Abstract][Full Text] [Related]
6. Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus.
Yue Y; Pan X; Hakim CH; Kodippili K; Zhang K; Shin JH; Yang HT; McDonald T; Duan D
Hum Mol Genet; 2015 Oct; 24(20):5880-90. PubMed ID: 26264580
[TBL] [Abstract][Full Text] [Related]
7. Dual AAV Gene Therapy for Duchenne Muscular Dystrophy with a 7-kb Mini-Dystrophin Gene in the Canine Model.
Kodippili K; Hakim CH; Pan X; Yang HT; Yue Y; Zhang Y; Shin JH; Yang NN; Duan D
Hum Gene Ther; 2018 Mar; 29(3):299-311. PubMed ID: 28793798
[TBL] [Abstract][Full Text] [Related]
8. Viral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle.
Ghosh A; Yue Y; Duan D
J Gene Med; 2006 Mar; 8(3):298-305. PubMed ID: 16385549
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).
Athanasopoulos T; Graham IR; Foster H; Dickson G
Gene Ther; 2004 Oct; 11 Suppl 1():S109-21. PubMed ID: 15454965
[TBL] [Abstract][Full Text] [Related]
10. Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors.
Lai Y; Yue Y; Liu M; Ghosh A; Engelhardt JF; Chamberlain JS; Duan D
Nat Biotechnol; 2005 Nov; 23(11):1435-9. PubMed ID: 16244658
[TBL] [Abstract][Full Text] [Related]
11. Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy.
Duan D
Mol Ther; 2018 Oct; 26(10):2337-2356. PubMed ID: 30093306
[TBL] [Abstract][Full Text] [Related]
12. Full-length dystrophin reconstitution with adeno-associated viral vectors.
Lostal W; Kodippili K; Yue Y; Duan D
Hum Gene Ther; 2014 Jun; 25(6):552-62. PubMed ID: 24580018
[TBL] [Abstract][Full Text] [Related]
13. Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector.
Bowles DE; McPhee SW; Li C; Gray SJ; Samulski JJ; Camp AS; Li J; Wang B; Monahan PE; Rabinowitz JE; Grieger JC; Govindasamy L; Agbandje-McKenna M; Xiao X; Samulski RJ
Mol Ther; 2012 Feb; 20(2):443-55. PubMed ID: 22068425
[TBL] [Abstract][Full Text] [Related]
14. Systemic Delivery of Adeno-Associated Viral Vectors in Mice and Dogs.
Wasala LP; Hakim CH; Yue Y; Yang NN; Duan D
Methods Mol Biol; 2019; 1937():281-294. PubMed ID: 30706404
[TBL] [Abstract][Full Text] [Related]
15. Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in duchenne muscular dystrophy muscle cells.
Gonçalves MA; Holkers M; Cudré-Mauroux C; van Nierop GP; Knaän-Shanzer S; van der Velde I; Valerio D; de Vries AA
Mol Ther; 2006 May; 13(5):976-86. PubMed ID: 16443396
[TBL] [Abstract][Full Text] [Related]
16. Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.
Nance ME; Duan D
Hum Gene Ther; 2015 Dec; 26(12):786-800. PubMed ID: 26414293
[TBL] [Abstract][Full Text] [Related]
17. From the smallest virus to the biggest gene: marching towards gene therapy for duchenne muscular dystrophy.
Duan D
Discov Med; 2006 Jun; 6(33):103-8. PubMed ID: 17234143
[TBL] [Abstract][Full Text] [Related]
18. Whole body skeletal muscle transduction in neonatal dogs with AAV-9.
Yue Y; Shin JH; Duan D
Methods Mol Biol; 2011; 709():313-29. PubMed ID: 21194038
[TBL] [Abstract][Full Text] [Related]
19. Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy.
Wasala NB; Yue Y; Lostal W; Wasala LP; Niranjan N; Hajjar RJ; Babu GJ; Duan D
Mol Ther; 2020 Mar; 28(3):845-854. PubMed ID: 31981493
[TBL] [Abstract][Full Text] [Related]
20. Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog.
Koo T; Okada T; Athanasopoulos T; Foster H; Takeda S; Dickson G
J Gene Med; 2011 Sep; 13(9):497-506. PubMed ID: 22144143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
